Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Patient enrollment begins in phase II trial of ThGRF in HIV-related lipodystrophy

May 26, 2003

CPMP contraindicates concomitant use of repaglinide and gemfibrozil

May 26, 2003

Higher GI-related expenses for Fosamax patients versus Actonel patients

May 26, 2003

PDE inhibitor counteracts sexual dysfunction associated with fluoxetine use

May 26, 2003

New tissue-selective androgen receptor modulators discovered at Merck

May 23, 2003

Preparation and use of new GSK-3 inhibitors claimed by Servier

May 23, 2003

FDA review date set for Crestor

May 22, 2003

European introduction of contraceptive transdermal matrix patch begins

May 21, 2003

Arginine supplementation to be studied for sickle cell disease

May 21, 2003

Symlin dose-titration study results reported

May 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...